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Mondia whitei (Hook.f.) Skeels is an important endangered medicinal and commercial
plant in South Africa. In vitro propagation systems are required for biomass production
and bioactivity analysis to supplement wild resources/stocks. Adventitious roots from
somatic embryogenic explants using suspension culture and ex vitro-grown plants
produced via somatic embryogenesis were established using different plant growth
regulator treatments. The adventitious root biomass and different parts of ex vitro-grown
and mother plants were used to investigate the potential for acetylcholinesterase (AChE)
and antibacterial activities. Adventitious roots derived from 2.5 µM indole-3-acetic acid
(IAA) treatments and ex vitro-grown plants derived from meta-topolin riboside and IAA
treatments gave the best AChE and antibacterial activities. The in vitro-established
M. whitei and ex vitro biomass have comparable ability to function as inhibitors of
acetylcholinesterase and antibacterial agents, and can be used as potent bioresources
in traditional medicine.
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INTRODUCTION
Mondia whitei (Hook.f.) Skeels is an important endangered medicinal plant included in
the Red Data List of South African plants as a result of its over-exploitation for various
medicinal uses (SANBI, 2013; Baskaran et al., 2015; Van Wyk, 2015). The conservation
status and medicinal importance requires the development of an efficient mass propagation
system. The plant’s root is used in the treatment of various diseases including those related
to nervous conditions (Gelfand et al., 1985; Noumi et al., 1998; Oketch-Rabah, 2012;
Baskaran et al., 2015; Van Wyk, 2015). Accordingly, assay of acetylcholinesterase (AChE:
primary cholinesterase enzyme for nerve agents) and antibacterial properties for numerous
clinical problems caused by bacteria needs to be examined in M. whitei. The in vitro
established micropropagated plants requires evaluation for bioactivity to ascertain if the
medicinal properties remains unchanged (Nagarajan et al., 2011; García-Pérez et al., 2012;
Baskaran et al., 2014). Many bacterial strains (for example, Enterococcus faecalis) are becoming
Frontiers in Pharmacology | www.frontiersin.org 1 October 2016 | Volume 7 | Article 335
fphar-07-00335 September 29, 2016 Time: 16:25 # 2
Baskaran et al. Mondia whitei- Root Culture and Bioactivity
resistant to antibiotics; therefore, the search for potent medicinal
plants represent a natural source that requires exploration.
Furthermore, the application of biotechnological techniques has
permitted harvesting and evaluation of in vitro regenerated
plants and plant materials at various stages of plant growth
and development (Nagarajan et al., 2011; García-Pérez et al.,
2012; El-Bakry et al., 2014). A report of in vitro adventitious
root culture and ex vitro-grown plants derived from somatic
embryogenesis are required to test the bioactivity to support
and utilization in medicinal systems as well as to preserve
existing M. whitei populations. Establishing adventitious roots
by suspension culture and ex vitro-grown plants from somatic
embryogenetic origin would accelerate large-scale biomass and
conservation in addition to supplementing pharmaceutical
products to study the biological significance of the species
bioactivity (Cui et al., 2010; Ho et al., 2013; Baskaran et al.,
2014).
In vitro culture developed plant biomass has found
pharmacological applications worldwide (García-Pérez et al.,
2012; Ho et al., 2013). Acetylcholinesterase (AChE: primary
cholinesterase enzyme) functions as a neurotransmitter and the
assay of AChE activity plays an important role in diagnostic,
nerve agents, in vitro characterization of toxins and drugs,
including potential treatments for Alzheimer’s disease (Pohanka
et al., 2011). Numerous bacterial diseases, including diarrhea,
can be alleviated by extracts from various parts of in vitro and
ex vitro-grown plants (Nagarajan et al., 2011; García-Pérez et al.,
2012). The aim of this study therefore, was to develop a simple
and efficient protocol for the production of adventitious roots
using somatic embryogenic explants in suspension culture and to
examine the AChE and antibacterial activities from the biomass
of the adventitious roots and different parts of ex vitro-grown
plants derived via somatic embryogenesis, using the mother plant
for comparison. The hormonal effects of the adventitious root
and somatic embryogenesis-derived ex vitro plants of M. whitei
biomass on AChE-inhibition and antibacterial activities were
also determined.
MATERIALS AND METHODS
Production of Adventitious Roots in
Suspension Culture
Torpedo stage somatic embryos (SEs) of M. whitei were collected
using a previously described somatic embryogenesis protocol
(Baskaran et al., 2015) on solid (8 g L−1 agar) MS (Murashige
and Skoog, 1962) medium with 40 g L−1 sucrose, 20 µM 2,4-
D, and 1 µM TDZ. The embryos (approximately 7 – 10) were
transferred to 250 mL Erlenmeyer flasks containing 50 mL liquid
MS medium with 30 g L−1 sucrose for induction of roots for
4 weeks. The roots (1 g L−1, 3–5 cm long) were transferred
to 50 mL liquid MS medium containing 30 g L−1 sucrose plus
2.5 – 10 µM indole-3-acetic acid (IAA) or indole-3-butyric acid
(IBA) and 2.5 – 15 µM naphthaleneacetic acid (NAA) in a
250 mL Erlenmeyer flask to optimize a concentration of auxin
for enhancement of adventitious root biomass for 8 weeks. The
liquid cultures were maintained on an orbital shaker at 100 rpm
at 25 ± 2◦C and light intensity of 40 µmol m−2 s−1 provided
by cool white fluorescent light (OSRAM L 58 W/740, South
Africa) with a 16 h photoperiod. All experiments were conducted
three times with five replicates per treatment. In all experiments,
medium lacking plant growth regulators served as controls. The
chemicals used were of analytical grade (Biolab, South Africa;
Oxoid, England and Sigma, USA). All media were adjusted to pH
5.8 with 0.1 N NaOH and/or 0.1 N HCl and autoclaved at 121◦C
for 20 min.
Roots were filtered through sieves (200 µm), and the fresh
weight (FW) measured after rinsing once with sterile distilled
water and blotting away the surface water. The roots were dried
at 50◦C for 1 day, and the root dry weight (DW) was recorded.
Adventitious root growth ratio was calculated as harvested DW
(g) - inoculated DW (g)/inoculated DW (g). The data were
statistically analyzed for analysis of variance (ANOVA), and
are presented as mean ± standard error of three independent
experiments. Treatment means were separated using Duncan’s
multiple range test at 5% probability level. All statistical analysis
was done using SPSS for Windows version 23 (SPSS Inc., Chicago,
IL, USA).
Ex vitro Plants from Somatic
Embryogenesis
The 18-month-old somatic embryogenesis system produced
(Baskaran et al., 2015) ex vitro-grown plants of M. whitei derived
from different treatments [50 g L−1 sucrose + 20 µM 2,4-
dichlorophenoxy acetic acid (2,4-D), 40 g L−1 sucrose + 20 µM
2,4-D + 1 µM thidiazuron (TDZ), 35 g L−1 sucrose + 20 µM
picloram + 1 µM benzyladenine (BA), 20 g L−1 sucrose +
0.5 µM meta-topolin riboside (mTR) + 0.25 µM IAA and 20 g
L−1 sucrose + 0.5 µM kinetin (Kin) + 0.25 µM IAA; Tables 1
and 2] were used for the bioassay studies.
Different plant materials (root, leaf, and stem) were harvested
from ex vitro-grown [1:1 (v/v) vermiculite:soil mixture under
greenhouse conditions (25 ± 2◦C under natural photoperiod
conditions and a midday PPF of 950 ± 50 µmol m−2 s−1)] and
mother plant (15-years-old) at the same time period (to avoid
seasonal differences), washed thoroughly with sterile water and
dried in an oven set at 50◦C in the dark.
Bioactivity Studies
The oven-dried plant materials (ex vitro-grown, mother plant
and adventitious root: 1 g powder each) were extracted with 70%
(v/v) methanol (100 mL) using a sonication bath for 1 h. The
extracts were filtered through a Büchner funnel using Whatman
no. 1 filter paper and the solvent evaporated under reduced
pressure at 30◦C. Dried extracts were kept at 4◦C until use. Each
extract was tested for acetylcholinesterase (AChE) inhibitory and
antibacterial properties. The bioactivity studies from in vitro, ex
vitro, and mother plant materials of M. whitei are described by a
schematic diagram (Figure 1).
AChE-Inhibitory Assay
The colorimetric method of Ellman et al. (1961) using a 96-well
microplate as described by Fawole et al. (2010) was used. Each
sample was evaluated in triplicate. Galantamine was used as a
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TABLE 1 | Acetylcholinesterase-inhibition in adventitious roots and various plant parts of ex vitro and garden-grown mother plants of Mondia whitei.
Sucrose (g L−1) + PGR
treatment (µM)
Source of plant
material
Plant part AChE-inhibition
IC50 (mg ml−1)
Control
30 + 2.5 IAA
30 + 10 IAA
30 + 2.5 IBA
30 + 10 IBA
30 + 2.5 NAA
30 + 10 NAA
30 + 15 NAA
50 + 20 2,4-D
40 + 20 2,4-D + 1 TDZ
35 + 20 picloram + 1 BA
20 + 0.5 mTR + 0.25 IAA
20 + 0.5 Kin + 0.25 IAA
In vitro culture
Ex vitro plant
Mother plant
Adventitious root
Root
Leaf
Stem
Root
Leaf
Stem
Root
Leaf
Stem
Root
Leaf
Stem
Root
Leaf
Stem
Root
Leaf
Stem
2.13 ± 0.21 ef
1.33 ± 0.14 b
3.60 ± 0.18 hi
3.57 ± 0.46 hi
2.57 ± 0.15 fg
3.44 ± 0.37 hi
3.35 ± 0.17 hi
3.91 ± 0.20 i
0.81 ± 0.14 a
2.96 ± 0.20 gh
2.00 ± 0.12 de
2.29 ± 0.18 ef
0.66 ± 0.25 a
1.72 ± 0.26 cd
2.13 ± 0.29 ef
2.13 ± 0.29 ef
3.90 ± 0.22 i
1.14 ± 0.15 b
0.88 ± 0.17 a
0.65 ± 0.09 a
1.05 ± 0.24 b
0.88 ± 0.10 a
1.67 ± 0.21 cd
1.30 ± 0.17 b
2.61 ± 0.22 fg
1.32 ± 0.60 b
PGR, Plant growth regulator. IC50 for galantamine (positive control) = 1.56 ± 0.18 µM. Values in bold font are considered significantly higher AChE-inhibitory activity.
Results are mean ± standard error (n = 3). Means followed by same letters in each column are not significantly different (P = 0.05) using Duncan’s multiple range test.
positive control. Following the calculation of the rate of reaction
for each sample, galantamine or blank, the percentage inhibition
was calculated using the formula: AChE inhibition (%) = [1 –
(sample reaction rate/blank reaction rate)] × 100. A non-linear
regression analysis was done using GraphPad Prism (version
4.03) software for the determination of the IC50 values. Data
were subjected to analysis of variance (SPSS, version 23.0), and
significant mean values were further separated using Duncan’s
multiple range test.
Antibacterial Assay
The microtiter bioassay (Eloff, 1998) was used to determine
antibacterial activity. Extracts were tested against Gram-positive
bacteria (Bacillus subtilis [ATCC 6051], E. faecalis [ATCC
19433], Micrococcus luteus [ATCC 4698], and Staphylococcus
aureus [ATCC 12600]) and Gram-negative bacteria (Escherichia
coli [ATCC 11775] and Klebsiella pneumoniae [ATCC 13883]).
A positive control, neomycin (µg ml−1 in the first well) was used
against each bacterial strain. Each determination was done in
duplicate, and the assay was repeated twice.
RESULTS AND DISCUSSION
Production of Adventitious Roots
Root induction was achieved using the torpedo-stage somatic
embryo explants in liquid MS medium containing 30 g L−1
sucrose after 4 weeks (Figures 2A,B). The adventitious roots were
established from root explants cultured in liquid MS medium
containing 30 g L−1 sucrose and various concentrations of
auxins (IAA, IBA, and NAA; Figure 2C). Normal adventitious
roots form, but require auxins in vitro (Baskaran and Jayabalan,
2009; Cui et al., 2010; El-Bakry et al., 2014; Steffens and
Rusmussen, 2016). Increased concentrations (>2.5 µM) of
auxins improved biomass production (>6.79 g/flask FW and
>2.00 g/flask DW; Figures 2D and 3), and the highest production
of biomass (20.34 g/flask FW and 4.37 g/flask DW) as well
as a good growth ratio was observed on medium containing
10 µM NAA (Figures 2E and 3). The biomass production was
markedly suppressed with an increased concentration (15 µM)
of NAA (Figure 3). High auxin levels are often suppressors for
adventitious root growth and production of biomass (Baskaran
and Jayabalan, 2009; Cui et al., 2010). In this study, the growth
ratio was lower in control, 2.5 µM IAA and 15 µM NAA
(Figure 3). These results indicate that the type of auxin and
its concentration is important for growth of adventitious roots
and biomass production and were in accordance with other
previous reports (Baskaran and Jayabalan, 2009; El-Bakry et al.,
2014).
AChE-Inhibitory and Antibacterial
Activities
In this study, AChE-inhibitory activity was observed in
adventitious roots, different plant parts of ex vitro-grown plants
(Figures 2F,G) and the mother plant of M. whitei (Table 1).
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TABLE 2 | Antibacterial activity of adventitious roots and various plant parts of ex vitro and garden-grown mother plants of M. whitei.
Sucrose (g L−1) + PGR
treatment (µM)
Source of plant
material
Plant part Minimum inhibitory concentration (mg ml−1)
B.s +ve E.f +ve M.l +ve S.a +ve E.c −ve K.p −ve
Control
30 + 2.5 IAA
30 + 10 IAA
30 + 2.5 IBA
30 + 10 IBA
30 + 2.5 NAA
30 + 10 NAA
30 + 15 NAA
50 + 20 2,4-D
40 + 20 2,4-D + 1 TDZ
35 + 20 Pic + 1 BA
20 + 0.5 mTR + 0.25 IAA
20 + 0.5 Kin + 0.25 IAA
Neomycin (positive control)
In vitro culture
Ex vitro plant
Mother plant
Adventitious
root
Root
Leaf
Stem
Root
Leaf
Stem
Root
Leaf
Stem
Root
Leaf
Stem
Root
Leaf
Stem
Root
Leaf
Stem
–
0.39
0.195
0.39
0.39
0.195
3.125
0.39
0.39
0.098
1.56
0.098
0.098
1.56
0.098
0.098
1.56
0.098
0.39
0.195
0.098
0.098
1.56
0.098
0.098
0.39
0.098
0.024
3.125
3.125
1.56
1.56
1.56
3.125
3.125
1.56
1.56
0.195
0.195
1.56
0.098
0.195
0.195
0.098
0.098
0.39
0.098
0.098
1.56
0.098
0.195
3.125
0.78
0.098
0.012
1.56
0.39
0.39
0.39
0.39
3.125
1.56
1.56
3.125
3.125
3.125
3.125
3.125
3.125
3.125
3.125
1.56
1.56
3.125
3.125
3.125
0.78
3.125
1.56
0.78
3.125
0.0061
3.125
1.56
1.56
1.56
1.56
3.125
1.56
1.56
1.56
6.25
6.25
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
6.25
6.25
12.5
12.5
6.25
6.25
3.125
0.0061
3.125
1.56
1.56
3.125
1.56
3.125
1.56
0.39
3.125
3.125
3.125
6.25
3.125
6.25
6.25
6.25
6.25
1.56
3.125
3.125
3.125
1.56
1.56
3.125
0.78
3.125
0.0015
0.78
0.39
0.39
1.56
1.56
1.56
1.56
0.39
1.56
3.125
3.125
6.25
6.25
3.125
3.125
3.125
3.125
1.56
1.56
1.56
3.125
1.56
1.56
6.25
0.78
3.125
0.0061
Extracts with values in bold font are considered very active (MIC < 1 mg ml−1). Results are mean ± standard error (n = 3). PGRs, Plant growth regulators. MIC (mg
ml−1); B.s, Bacillus subtilis; E.f, Enterococcus faecalis; M.l, Micrococcus luteus; S.a, Staphylococcus aureus; E.c, Escherichia coli; K.p, Klebsiella pneumoniae.
FIGURE 1 | A schematic diagram for bioactivity from adventitious roots using liquid cultures and ex vitro-grown somatic embryos derived plants and
mother plant of M. whitei.
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FIGURE 2 | Production of adventitious roots using liquid cultures and ex vitro-grown somatic embryos derived plants of M. whitei. (A) Root induction
from torpedo-stage somatic embryo explants after 2 weeks culture. (B) Root induction after 4 weeks culture. (C) Root explants for adventitious root culture.
(D) Production of adventitious roots in 10 µM IAA after 8 weeks culture. (E) Adventitious roots in 10 µM NAA. (F) Establishment of ex vitro-grown plants in the
greenhouse. (G) Ex vitro-grown plants after 18 months.
FIGURE 3 | Different concentrations of auxins for adventitious root growth [fresh weight (FW) and dry weight (DW)] and growth ratio of M. whitei.
Results are mean ± standard error (n = 3). The bar containing different letters in graph indicates significant differences at P = 0.05 of significance using Duncan’s
multiple range test.
The root and stem of mother plant exhibited significant
AChE-inhibitory activity, but this did not differ significantly
with those of the adventitious roots (2.5 µM IAA) and roots
of ex vitro-grown plants from 20 g L−1 sucrose + 0.5 µM
mTR + 0.25 µM IAA and 20 g L−1 sucrose + 0.5 µM Kin
+ 0.25 µM IAA treatments, respectively (Table 1). The IC50
values recorded in extracts of adventitious roots derived from
control, IAA (10 µM), IBA, and NAA treatments and roots,
leaves and stems of ex vitro-grown plants derived from 35 g
L−1 sucrose + 20 µM picloram + 1 µM BA treatments did not
exhibit good AChE-inhibitory activity (Table 1). The inhibitory
activity was significantly higher in roots (50 + 20 2,4-D), leaves
(40 g L−1 sucrose + 20 2,4-D + 1 TDZ; 20 g L−1 sucrose
+ 0.5 mTR + 0.25 IAA; 20 g L−1 sucrose + 0.5 Kin + 0.25
IAA) and stems (20 g L−1 sucrose + 0.5 mTR + 0.25 IAA)
of ex vitro plants (Table 1). Overall, AChE-inhibitory activity
was good in all parts of ex vitro-grown plants derived from
20 g L−1 sucrose + 0.5 mTR + 0.25 IAA treatments (Table 1).
These results indicate that the AChE-inhibitory activity differs
within the treatments and plant parts. The superior inhibitory
effects demonstrated by IAA and mTR treatments suggest
that they may be regulating certain secondary compounds
during in vitro and ex vitro processes. Moreover, adventitious
roots and ex vitro-grown plants treated with specific PGRs
in different concentrations could be an efficient substitute
for improving wild populations. In addition, the therapeutic
potential of ex vitro plants may influence somatic embryogenic
phases. Ex vitro-grown and in vitro regenerated plants
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with PGR treatments have been reported with potential
bioactivity in other plant species (Baskaran et al., 2014).
Antibacterial activity from adventitious roots and different
parts of ex vitro and mother plants of M. whitei showed
antibacterial activity against tested human pathogenic bacteria
(Table 2). The bioactivity test in in vitro established tissues has
been reported to support plants used in traditional medicine
and prevent loss of wild populations (Baskaran et al., 2014).
Extracts of adventitious roots showed good activity against both
Gram-positive (B. subtilis and M. luteus) and Gram-negative
(E. coli and K. pneumoniae) bacteria; however, no bioactivity was
observed for adventitious roots against Gram-positive (E. faecalis
and S. aureus) bacteria (Table 2). Active secondary metabolism
has been reported in adventitious roots of ginseng (Yu et al., 2000;
Hahn et al., 2003). The higher bioactivity was recorded in extracts
of different parts of ex vitro-grown plants derived from different
treatments and were more potent against B. subtilis and E. faecalis
bacteria (Table 2). On the other hand, none of the extracts of
the ex vitro-grown and mother plants exhibited activity against
both Gram-positive (M. luteus and S. aureus) and Gram-negative
(E. coli and K. pneumoniae) bacteria (Table 2). The results of
this study indicate that the antibacterial activity depended on the
source of plant material, tissue type and concentration of PGRs
in the treatments and are in accordance with results obtained
with Agapanthus praecox (Baskaran et al., 2014). Accumulation
of secondary compounds as regulated by PGRs during in vitro
and ex vitro-growth processes may have affected the bioactivity.
However, the biochemical mechanisms surrounding these still
needs to be investigated in the plant species. The results of the
present study suggest that in vitro and ex vitro-grown plant
parts as obtained with specific PGR treatments can effectively
be used for the treatment of bacterial ailments in traditional
medicine.
CONCLUSION
Pharmacological investigations were conducted to confirm
acetylcholinesterase (AChE) and antibacterial activities of in vitro
adventitious roots and ex vitro-acclimatized plants of M. whitei.
The bioactivity was found to vary with specific concentration and
combinations of PGRs during the in vitro phases. Established
in vitro plants had stronger bioactivity and ability to function
as inhibitors of acetylcholinesterase and antibacterial agents and
thus offer potential for use as potent bioresources in traditional
medicine and other commercial applications.
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